Botanical species · safety record

Cymbopogon citratus

The EFSA Compendium of Botanicals holds 1 constituent measurement, 3 adverse-effect records and 1 genotoxicity assay for Cymbopogon citratus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cymbopogon citratus (DC.) Stapf

1Constituent measurements

4Safety records

3Cited sources

112Licensed products (Canada)

Also recorded as

Andropogon citratus DC.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 112 licensed products naming Cymbopogon citratus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Fresh

Source material stated

Aerial parts
Herb top
Leaf
Leaf Stalk
Stem
Stem and leaf
Stem and leaves
Whole plant

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Myrcene	Live plants	Essential oil	20 Percent	GC-MS	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Stomach	—	Essential oil (as part-nature)	Rat (as animal)	Short-term toxicity	Resolve DOI
Digestive	Stomach	—	Essential oil (as part-nature)	Rat (as animal)	Short-term toxicity	Resolve DOI
Other toxicities	—	Leaves	Solvent extraction	House mouse (as animal)	Acute toxicity	No resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

Outcome	Endpoint	Test	Tested organism	Metabolic activation	Source
Positive	gene mutation	bacterial gene mutation assay	Salmonella typhimurium (as organism)	No data	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Logarto Parra, A., Silva Yhebra, R., Guerra Sardinas, I., Iglesias Buela, L. Comparative study of the assay of Artemia salina L. and the estimate of the medium lethal dose (LD50 value) in mice, to determine oral acute toxicity of plant extracts. . Phytomedicine : international journal of phytotherapy and phytopharmacology, 2001, vol. 8, no. 5, p. 395-400.
Fandohan, P., Gnonlonfin, B., Laleye, A., Gbenou, J. D., Darbouxc, R., Moudachirou, M. Toxicity and gastric tolerance of essential oils from Cymbopogon citratus, Ocimum gratissimum and Ocimum basilicum in Wistar rats . Food and chemical toxicology, 2008, vol. 46, no. 7, p. 2493-2497. DOI
RIVERA, IG., MARTINS, MT., SANCHEZ, PS., SATO, MIZ., COELHO, MCL., AKISUE, M., AKISUE, G. GENOTOXICITY ASSESSMENT THROUGH THE AMES TEST OF MEDICINAL-PLANTS COMMONLY USED IN BRAZIL . Environmental toxicology and water quality, 1994, vol. 9, no. 2, p. 87-93. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature